Malignant esophageal obstruction in 24 patients was treated using the neodymium:ytrium, aluminum, garnet laser. There were 15 males and nine females; the average age was 70.9 years. There were 17 adenocarcinomas and seven squamous cell carcinomas, with two of these being recurrent after radiation th
Endoscopic laser therapy of the watermelon stomach
β Scribed by David J. Bjorkman; Kenneth N. Buchi
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 396 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Endoscopic laser therapy has been used in the treatment of vascular lesions throughout the gastrointestinal tract. The βwatermelon stomachβ is a pattern of vascular ectasia in the gastric antrum that results in chronic gastrointestinal blood loss and iron deficiency anemia.
We have treated 7 transfusion dependent patients with a watermelon stomach using endoscopic laser therapy. Four of these patients were treated with the argon laser and 3 with the Nd:YAG laser. Patient age and prior transfusion requirements were similar in both groups. The mean number of treatments to obliterate vascular lesions and eliminate the need for transfusions was 5.75 Β± 0.89 (SEM) for the argon laser and 2.33 Β± 0.27 for the Nd:YAG laser (P < 0.05). Lesions recurred and required retreatment in 1 patient treated with the NdrYAG laser and 3 patients treated with the argon laser (mean followβup of 35 months). We conclude that endoscopic laser therapy with either the argon or Nd:YAG laser is an effective treatment modality for antral vascular ectasia (watermelon stomach). The Nd:YAG laser requires fewer treatment sessions than the argon laser to obliterate the lesions without increased risk of complications. Β© 1992 WileyβLiss, Inc.
π SIMILAR VOLUMES
The prograde and retrograde approaches to the treatment of malignant esophageal obstruction with the NdYAG, or neodymium: yttrium, aluminum, garnet, laser are compared. With the prograde technique, tumor destruction proceeds from the proximal to the distal tumor margin. In retrograde treatment, the
Endoscopic laser therapy provides effective symptomatic palliation for patients with squamous cell carcinoma of the esophagus. To investigate whether this treatment also prolongs survival, a retrospective case-control study was performed. Ten patients with squamous cell carcinoma of the esophagus, d